Cinefootage Visuals/iStock via Getty Images I hope those who invested alongside me in the nuclear energy sector over the past few years heeded my warnings—that position sizing is more important than security selection and that the best course of action was to use the NUKZ ETF for most of one's exposure. Broad indexes are great for this kind of trade, where an individual firm's volatility can be ve...
Cinefootage Visuals/iStock via Getty Images I hope those who invested alongside me in the nuclear energy sector over the past few years heeded my warnings—that position sizing is more important than security selection and that the best course of action was to use the NUKZ ETF for most of one's exposure. Broad indexes are great for this kind of trade, where an individual firm's volatility can be very harmful to a portfolio. There were still some individual stocks I discussed here on Seeking Alpha, mostly advanced reactor firms like NANO Nuclear Energy ( NNE ), but they have fared far worse than the ETF since risk began fleeing the market back in October. This is one where my advice applies doubly so, and I think I made that fairly clear in my last coverage, also back in October . Not much has changed about my core long-term thesis since then—just the price of the stock, which I published at the top by happenstance—although things are changing within NNE itself that warrant renewed coverage. The market went from risk-on to risk-off quickly, and nuclear reactor firms have been in drawdown since. This has been a time when I've added, albeit slowly and lightly. Data by YCharts These kinds of stocks are the reason I make those mentions of position sizing; it might still be a winner in the long term, but if a decline in price like this shakes you out, you'll never hold it long enough for it to become a winner. You can avoid that by owning a small position so that large percentage drawdowns end up as small nominal drawdowns. NANO Nuclear Energy Overview Quickly, the bull case for advanced nuclear reactors is that they strip away many of the issues with large reactors while also providing a workable solution to the rapidly approaching gap between AI energy demand and energy grid capacity that doesn't involve burning endless amounts of coal (we will still need lots of natural gas power even with nuclear everywhere, I imagine). NNE produces an even smaller variant of the “smal...
gorodenkoff/iStock via Getty Images Shares of Legence Corp. ( LGN ) on Wednesday rose after a large secondary offering tied to a stake sale by Blackstone ( BX ) drew significantly more investor interest than available shares, Bloomberg News reported, citing people familiar with the matter. The $723 million transaction was multiple times oversubscribed, with demand reaching roughly five times the s...
gorodenkoff/iStock via Getty Images Shares of Legence Corp. ( LGN ) on Wednesday rose after a large secondary offering tied to a stake sale by Blackstone ( BX ) drew significantly more investor interest than available shares, Bloomberg News reported, citing people familiar with the matter. The $723 million transaction was multiple times oversubscribed, with demand reaching roughly five times the size of the offering after it was increased during the marketing process. Allocation favors long-term investors Most of the shares were distributed to long-only investors, along with some existing shareholders. The identities of the investors weren't disclosed. Shares rise following pricing The offering was priced at $54 per share, representing about an 8% discount to the company’s closing price on April 2, the last trading day before the deal was marketed earlier in the week. Following the sale, Legence ( LGN ) shares rose about 2.4% in morning trading in New York, reaching approximately $56.28. Transaction reflects continued investor interest The strong demand for the offering suggests continued investor appetite for shares in the building systems and HVAC services sector, even as large shareholders look to reduce positions through block trades. Blackstone’s ( BX ) sale comes as private equity firms continue to monetize holdings amid fluctuating market conditions, with pricing discounts commonly used to attract institutional buyers in large secondary offerings. More on Legence Legence Corp. (LGN) Q4 2025 Earnings Call Transcript Legence Corp.'s Surge Justifies A Respectful Downgrade Legence prices upsized $723M secondary offering at $54.00 a share Historical earnings data for Legence Financial information for Legence
Levi's CEO Michelle Gass said that both celebrity ad campaigns and organic pop culture moments have contributed to Levi's boosted outlook as the jeans brand collaborated with Beyonce and were featured on the fashion forward FX series 'Love Story.' Gass also discussed supply chain consideration as US-based companies face higher transportation costs and tariffs on manufacturing. (Source: Bloomberg)
Levi's CEO Michelle Gass said that both celebrity ad campaigns and organic pop culture moments have contributed to Levi's boosted outlook as the jeans brand collaborated with Beyonce and were featured on the fashion forward FX series 'Love Story.' Gass also discussed supply chain consideration as US-based companies face higher transportation costs and tariffs on manufacturing. (Source: Bloomberg)
FilippoBacci/iStock via Getty Images International financial stocks have been among the notable beneficiaries of the broader resurgence in non-U.S. equities in 2026. Strong investor demand for single-country and emerging market exposures, particularly in Brazil and Japan, has translated into meaningful year-to-date gains for select foreign financial names. The following list ranks the top 10 forei...
FilippoBacci/iStock via Getty Images International financial stocks have been among the notable beneficiaries of the broader resurgence in non-U.S. equities in 2026. Strong investor demand for single-country and emerging market exposures, particularly in Brazil and Japan, has translated into meaningful year-to-date gains for select foreign financial names. The following list ranks the top 10 foreign financial stocks by year-to-date performance, spanning financial exchanges, asset management, insurance, and banking across Israel, Canada, the United Kingdom, Brazil, Japan, Kazakhstan, and Singapore, with market capitalizations ranging from approximately $3 billion to $86 billion. Below is a list of the top 10 foreign financial stocks ranked by their year-to-date performance. The list includes companies across various financial subsectors, such as financial exchanges, asset management, insurance, and banking, and features market capitalizations ranging from approximately $3B to $86B. The list is topped by The Tel-Aviv Stock Exchange Ltd. ( TVAVF ), with a YTD performance of over 50%. Sprott Inc. ( SII:CA ) and Beazley plc ( BZLEY ) follow closely behind, both delivering gains above 40%. B3 S.A. - Brasil, Bolsa, Balcão ( BOLSY ) and Mebuki Financial Group, Inc. ( MEBUF ) round out the top five, representing geographic diversity with Brazil and Japan respectively. Japanese financial institutions feature prominently on the list, with Tokio Marine Holdings, Inc. ( TKOMY ) and Resona Holdings, Inc. ( RSHGY ) both posting gains above 23%. Freedom Holding Corp. ( FRHC ) from Kazakhstan and UK-based Marex Group plc ( MRX ) also rank among the top performers, while Singapore Exchange Ltd. ADR ( SPXCY ) closes out the top 10. Here is the list: The Tel-Aviv Stock Exchange Ltd. ( TVAVF ), YTD perf: 50.40% Sprott Inc. ( SII:CA ), YTD perf: 44.20% Beazley plc ( BZLEY ), YTD perf: 42.16% B3 S.A. - Brasil, Bolsa, Balcão ( BOLSY ), YTD perf: 32.12% Mebuki Financial Group, Inc. ( MEBUF ...
The popular open source VPN maker is the second high-profile developer to say Microsoft locked his account without notifying him and are blocking their ability to send software updates to users.
The popular open source VPN maker is the second high-profile developer to say Microsoft locked his account without notifying him and are blocking their ability to send software updates to users.
Axsome Therapeutics (NASDAQ: AXSM) , a midcap biotech, went public in 2015. Since then, the stock has delivered market-beating returns thanks to significant clinical and regulatory progress, as well as a portfolio of now-approved drugs that generate solid sales. Axsome Therapeutics might only be getting started. The company still has a deep pipeline and plenty of catalysts ahead. But does it have ...
Axsome Therapeutics (NASDAQ: AXSM) , a midcap biotech, went public in 2015. Since then, the stock has delivered market-beating returns thanks to significant clinical and regulatory progress, as well as a portfolio of now-approved drugs that generate solid sales. Axsome Therapeutics might only be getting started. The company still has a deep pipeline and plenty of catalysts ahead. But does it have what it takes to turn average investors into millionaires? If you had invested $50,000 into Axsome Therapeutics following its IPO, you would be sitting on close to $1 million today, given its compound annual growth rate of 33.32% over this period. Can the biotech pull off a similar performance through the next decade? That's unlikely, as it would give the company a market cap of about $157 billion, making it one of the largest drugmakers in the world. It's not impossible, to be clear, but it's an incredibly high bar to expect Axsome Therapeutics to match the performance it has had since 2015, when it started as a significantly smaller biotech stock . Image source: Getty Images. Continue reading
Julian Alvarez and Alexander Sorloth give Atletico Madrid a 2-0 victory over 10-man Barcelona in their Champions League quarter-final first leg at the Nou Camp.
Julian Alvarez and Alexander Sorloth give Atletico Madrid a 2-0 victory over 10-man Barcelona in their Champions League quarter-final first leg at the Nou Camp.
baranozdemir/E+ via Getty Images Canadian flight simulation company CAE Inc. ( CAE ) is reducing its global workforce by about 2% as part of a broader restructuring effort led by its recently appointed chief executive. Matthew Bromberg, who took over as CEO in August, informed employees that the company needs to adjust its operations in response to shifting market conditions. In a letter to staff,...
baranozdemir/E+ via Getty Images Canadian flight simulation company CAE Inc. ( CAE ) is reducing its global workforce by about 2% as part of a broader restructuring effort led by its recently appointed chief executive. Matthew Bromberg, who took over as CEO in August, informed employees that the company needs to adjust its operations in response to shifting market conditions. In a letter to staff, he said CAE ( CAE ) must take additional measures to adapt, citing weaker demand in segments of its civil aviation business alongside growing opportunities tied to defense and security amid geopolitical tensions. Job cuts and operational review underway The workforce reduction will impact roughly 280 positions across areas including procurement, contracts and technical functions. The company is also introducing an early retirement program in Canada. CAE ( CAE ) has begun evaluating operations at several international locations, including facilities in Barcelona, Brussels and Stockholm. In the United States, the company had already disclosed plans to close sites in Orlando’s Lee Vista area and in Broken Arrow, Oklahoma. Aviation slowdown weighs on civil business The restructuring comes as parts of the global aviation sector face pressure from economic uncertainty and ongoing supply chain constraints that have slowed aircraft deliveries. Aircraft groundings and reduced fleet expansion have also dampened demand for pilot hiring and training, affecting CAE’s core civil aviation services. Broader transformation plan in progress Bromberg, who joined CAE ( CAE ) from Northrop Grumman ( NOC ) , has outlined a multi-year plan aimed at improving profitability and reshaping the company’s operations. The strategy includes reallocating capital, streamlining assets and improving performance across business units. Earlier this year, CAE ( CAE ) said it would retire underperforming simulators used by commercial airlines and identified non-core businesses accounting for roughly 8% of its r...
Snap (NYSE:SNAP), a consumer technology and social platform, closed at $4.73 on Wednesday, down 1.46%. The stock is easing after earlier gains tied to a new health-focused advertising push. Investors are watching whether healthcare and pharmaceutical budgets can become a durable
Snap (NYSE:SNAP), a consumer technology and social platform, closed at $4.73 on Wednesday, down 1.46%. The stock is easing after earlier gains tied to a new health-focused advertising push. Investors are watching whether healthcare and pharmaceutical budgets can become a durable
jozzeppe/iStock Editorial via Getty Images Not A Phone Company Anymore Xiaomi ( XIACY ) has nearly wiped out half of its market cap since the September 2025 peak. This reminds me of the scary 74% pullback back in 2022. The company used to be a traditional smartphone company, with expanding market share in both mainland China and overseas. However, if you've been following its recent earnings, you ...
jozzeppe/iStock Editorial via Getty Images Not A Phone Company Anymore Xiaomi ( XIACY ) has nearly wiped out half of its market cap since the September 2025 peak. This reminds me of the scary 74% pullback back in 2022. The company used to be a traditional smartphone company, with expanding market share in both mainland China and overseas. However, if you've been following its recent earnings, you will notice three primary shifts. First, Xiaomi's total revenue mix has changed dramatically over the past two years. Smartphones used to be a key revenue driver but now Auto segment (mainly EV and AI initiatives) is quickly catching up. I expect Auto revenue to surpass Smartphone by the end of FY2026. Second, other AI bets are becoming eye-catching, such as physical robotics, AI agentic models, and even in-house chips. Its humanoid robots are currently deployed in its EV factories, conducting self-learning while improving work efficiency. Third, Smartphones' revenue growth and gross profit declined significantly in 2H FY2025, driven by higher memory costs. This has sharply reduced Xiaomi's net income. Three factors combined tell us one thing: Xiaomi is no longer a phone company, as it's making a crucial business transition toward EVs, AI and robotics, which is creating near-term growth headwinds. How do we value the stock? It might not be appropriate to compare directly with Tesla ( TSLA ), but I think the two share similarities in their business models. If Xiaomi fails to pivot and scale its AI initiatives, 17x P/E TTM could be a value trap. But if it's redefined as an AI company (AI integrated across its product ecosystem), then the stock is significantly undervalued. Given that reason, I initiated a Buy on Xiaomi's stock with a 3–5-year investment horizon. Keep in mind that XIACY trades on the OTC market, which is not sponsored. You may be charged a commission for each trade. Revenue Transition from Smartphones to EV and AI The company model To understand why the stock ...